Changes in left ventricular mass in children and adolescents during chronic dialysis

被引:68
作者
Mitsnefes, MM
Daniels, SR
Schwartz, SM
Khoury, P
Strife, CF
机构
[1] Childrens Hosp Res Fdn, Div Nephrol & Hypertens TCHRF5, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Dept Pediat, Div Nephrol & Hypertens, Cincinnati, OH 45221 USA
[3] Univ Cincinnati, Coll Med, Dept Pediat, Div Cardiol, Cincinnati, OH 45221 USA
关键词
pediatric dialysis; cardiac disease; left ventricular hypertrophy; hypertension;
D O I
10.1007/s004670000557
中图分类号
R72 [儿科学];
学科分类号
100202 [儿科学];
摘要
Left ventricular hypertrophy (LVH) is an independent risk factor for cardiac mortality in adults with end-stage renal disease (ESRD). It is prevalent in pediatric patients on chronic dialysis. The objectives of this study were to evaluate left ventricular mass (LVM) in children and adolescents at the initiation of dialysis and to assess its changes during chronic dialysis therapy. In this longitudinal analysis, 29 patients aged 4-18 years had an echocardiographic evaluation within 90 days of starting dialysis therapy and a follow-up study at least 6 months later. LVH was defined as LVM index (g/m(2.7)) > 95th percentile for normal children and adolescents. On the initial echocardiogram 20 of 29 (69%) patients had LVH and 24 patients (83%) had abnormal LV geometry (38% eccentric LVH, 31% concentric LVH, and 14% concentric remodelling). Patients with LVH were more likely to be on antihypertensive medications (16/20) than patients without LVH (3/9) (P=0.005). Repeat echocardiogram, performed after 10 +/-3 months on chronic dialysis, showed no significant difference in the mean LVM index (49.6 +/- 17.5 g/m(2.7) and 49.7 +/- 16.1 g/m(2.7), respectively) or in the prevalence of LVH or LV geometric pattern. However, 14 of 29 patients had a progressive increase in LVM index and 15 patients had regression. Multiple regression analysis showed that baseline LVM index (P=0.005) and interval change in indexed systolic blood pressure (P=0.027) were independent predictors for LVM index changes. In summary, LVH and abnormal LV geometry are already prevalent in children and adolescents with renal failure at the time of initiation of dialysis therapy, indicating that LVH develops during the pre-ESRD course. Early intervention to control blood pressure may be an important factor to improve and prevent progression of LVH in pediatric patients with ESRD.
引用
收藏
页码:318 / 323
页数:6
相关论文
共 32 条
[1]
REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE DIALYZED UREMIC PATIENTS ON LONG-TERM ANTIHYPERTENSIVE THERAPY [J].
CANNELLA, G ;
PAOLETTI, E ;
DELFINO, R ;
PELOSO, G ;
MOLINARI, S ;
TRAVERSO, GB .
KIDNEY INTERNATIONAL, 1993, 44 (04) :881-886
[2]
CANNELLA G, 1997, AM J KIDNEY, V30, P653
[3]
DELIGIANNIS A, 1984, P EDTA ERA, V21, P185
[4]
EFFECT OF GROWTH ON VARIABILITY OF LEFT-VENTRICULAR MASS - ASSESSMENT OF ALLOMETRIC SIGNALS IN ADULTS AND CHILDREN AND THEIR CAPACITY TO PREDICT CARDIOVASCULAR RISK [J].
DESIMONE, G ;
DEVEREUX, RB ;
DANIELS, SR ;
KOREN, MJ ;
MEYER, RA ;
LARAGH, JH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (05) :1056-1062
[5]
LEFT-VENTRICULAR MASS AND BODY SIZE IN NORMOTENSIVE CHILDREN AND ADULTS - ASSESSMENT OF ALLOMETRIC RELATIONS AND IMPACT OF OVERWEIGHT [J].
DESIMONE, G ;
DANIELS, SR ;
DEVEREUX, RB ;
MEYER, RA ;
ROMAN, MJ ;
DEDIVITIIS, O ;
ALDERMAN, MH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (05) :1251-1260
[6]
ECHOCARDIOGRAPHIC DETERMINATION OF LEFT-VENTRICULAR MASS IN MAN - ANATOMIC VALIDATION OF METHOD [J].
DEVEREUX, RB ;
REICHEK, N .
CIRCULATION, 1977, 55 (04) :613-618
[7]
DRUKKER A, 1981, P EUR DIAL TRANS, V18, P542
[8]
DYDYK AI, 1997, NEPHROL DIAL TRANSPL, V12, P945
[9]
LEFT-VENTRICULAR HYPERTROPHY IN END-STAGE RENAL-DISEASE ON PERITONEAL-DIALYSIS [J].
EISENBERG, M ;
PRICHARD, S ;
BARRE, P ;
PATTON, R ;
HUTCHINSON, T ;
SNIDERMAN, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (04) :418-419
[10]
Long-term evolution of cardiomyopathy in dialysis patients [J].
Foley, RN ;
Parfrey, PS ;
Kent, GM ;
Harnett, JD ;
Murray, DC ;
Barre, PE .
KIDNEY INTERNATIONAL, 1998, 54 (05) :1720-1725